MaxCare offers a consultative approach to specialty pharmacy by providing continuous and up-to-date formulary review and management for brand and biosimilar specialty drugs. MaxCare promptly applies clinical edits when necessary and consults the plan to allow for flexibility and autonomy. Specialty drugs are integrated with MaxCare’s suite of clinical programs and cost savings opportunities such as prior authorization, step therapy and quantity limits.
MaxOutcomes Specialty Care Program
The MaxOutcomes Specialty Care Program is designed to maximize outcomes of complex and costly medication treatments for both the plan sponsor and the patient, beyond the scope of MaxCare’s standard specialty program. It is designed to integrate different components affecting the patient’s healthcare such as the doctor’s office, ancillary services, and pharmacy, to help ensure therapy is completed successfully by the patient. In doing this, our clinical staff actively engages with the patient and prescriber to educate, ensure compliance, and review results. This will reduce costs associated with futile treatment and waste, increasing the plan’s investment in their employees’ healthcare.